Brief: AtriCure Q2 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0
23/07/2026 21:02
BRIEF-AtriCure Q2 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0 Jul 23 (Reuters) - AtriCure Q2 adjusted EBITDA USD 27.3 million vs. IBES estimate USD 19.9 million.
- Q2 revenue USD 153.6 million vs. IBES estimate USD 151.8 million
- Q2 gross profit USD 118.6 million
- Q2 operating income USD 9.7 million
- Q2 gross margin 77.2%
- outlook FY adjusted EPS USD 0.24-0.32 vs. IBES estimate USD 0.06
- outlook FY revenue USD 602-610 million vs. IBES estimate USD 605 million
- outlook FY adjusted EBITDA USD 85-89 million vs. IBES estimate USD 80.5 million
Recent news on AtriCure
See all newsBrief: Inspire Medical Systems, Inc. Announces Appointment Of Seasoned Medical Device Executive Michael H. Carrel To Its Board Of Directors
AtriCure Inc reports results for the quarter ended June 30 - Earnings Summary
AtriCure Q2 revenue beats estimates
Brief: AtriCure Q2 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0
AtriCure Q1 revenue beats estimates, co raises 2026 outlook